Abstract
A clinicopathologic study was made of 16 patients with amyloidosis and with clinical signs of intestinal pseudo-obstruction. Amyloid deposits in the small intestine were proved in all cases by endoscopic or intraoperative biopsies, and immunohistochemical study identified the chemical types of amyloid protein: amyloid A protein (AA) in 13 cases, light chain protein (AL) in two, and~2-micro globulin (AH) in one. Clinically, an acute self limiting obstructive condition was evident in 13 cases with AA, and 12 of them returned to normal bowel function after receiving total parenteral nutrition. Two cases with AL and one with AH presented chronic, intermittent, obstructive symptoms, and medical treatment, including total parenteral nutrition, was ineffective with no recovery of intestinal propulsion. Pathological examination of the necropsy specimens in seven cases showed considerable differences in the preferential sites of gastrointestinal deposits between the chemical types of amyloid; extensive infiltration and replacement of the muscularis propria by amyloid deposits throughout the gastrointestinal tract, especially the small intestine, were found in the AL and the AH cases, while amyloid deposits in the myenteric plexus without appreciable muscle infiltration were shown in the AA cases. These results show that intestinal pseudo-obstruction in patients with amyloidosis is caused by either myopathy or neuropathy, and that chemical types of amyloid may determine which of the two factors has the dominant affect on the bowel function.
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Intestinal pseudo-obstruction is a clinical syndrome characterised by symptoms and signs of intestinal obstruction despite the absence of mechanical blockage of the intestinal lumen. [1] [2] [3] Systemic amyloidosis often affects the gastrointestinal tract' S and may result in this condition.r" It is unclear, however, whether the impaired gastrointestinal motility is secondary to the effects of amyloid on the smooth muscle or on the autonomic nervous system, because there have been few reports assessing the clinicopathologic features in a considerable number of amyloidosis patients with intestinal pseudoobstruction.
Recently, biochemical analyses have shown that several different types of amyloid fibril protein exist in systemic amyloidosis. Light chain protein (AL) amyloid, which is of immunoglobulin origin, is found in primary or myeloma-associated amyloidosis. 9 10 Secondary amyloidosis associated with chronic inflammatory diseases consists of amyloid A (AA) protein.
11 12 AH amyloid consisting of~2-micro globulin is found in patients receiving longterm haemodialysis.v " It is now widely recognised that amyloidosis, rather than being a single disease entity, represents a group of diseases that have in common characteristic microscopic staining properties and electron microscopic fibrillar configuration. IS Correlations between the chemical types, however, of amyloid and histological or clinical features in amyloidosis patients with intestinal pseudo-obstruction have never been determined.
The aims of this study were: (a) to explore the distinguishing clinical characteristics between the patients with three types of amyloidosis who presented with clinical signs of intestinal pseudoobstruction, and (b) to examine the relations between the clinical features and pathological findings.
Methods

PATIENTS
Between 1978 and 1992, we saw 17 patients with amyloidosis who presented with clinical signs of intestinal obstruction. Of these, 11 patients initially came to the hospital complaining of abdominal distension, cramping, anorexia, vomiting, constipation or diarrhoea, and we found six in whom such clinical signs developed during the follow up of illness. The abdominal plain films of these patients showed abnormal accumulation of gastrointestinal gas, dilated loops of the small and large bowel, with occasional air-fluid values. Two patients had emergency laparotomy and no mechanical obstruction was found. In the other 14 patients, barium studies of the small and large intestine did not show any mechanical obstruction. The remaining patient showed a large mass in the jejunum, which was histopathologically diagnosed as an amyloid tumor. Excluding this exceptional case, we examined 16patients showing clinical signs of intestinal pseudo-obstruction.
IDENTIFICATION OF AMYLOID PROTEIN
One patient had primary amyloidosis, two had myeloma associated amyloidosis, one had haemodialysis associated amyloidosis, and 12 had secondary amyloidosis (rheumatoid arthritis in _eight, ankylosing spondylitis in one, adult Still's disease in one, polymyositis in one, and Crohn's disease in one). Using a long duodenofibrescope," endoscopic biopsy specimens of the jejunum showed amyloid deposits in 15 patients.
In the remaining patient, amyloid deposits of the jejunum were confirmed by intraoperative biopsy specimens. Using these specimens, chemical types of amyloid protein were identified by the avidin -biotin complex (ABC) method using anti-Azs", anti -Bj-microglobulin (1:500, Dako), and anti-prealbumin (1:500, Dako) antibodies. For a comparative evaluation of amyload protein, potassium permanganate (KMn04) treatment was performed before staining with Congo red." AA protein was identified by positive staining with anti -AA antibody and sensitivity to KMn04 reaction, while AL protein failed to stain with anti -AA, anti -Bj-micro - the ileocaecal valve), colon (mid-transverse), and rectum (lower part), three specimens, measuring 3 or 4 cm long and 0·5 cm wide and including all the layers of the wall, were obtained and embedded in paraffin wax. Sections of 5 urn thickness were stained with haematoxylin and eosin, Congo red, and azan stain. Immunohistochemical studies were performed by the ABC method using S-100 protein, anti-AA, and anti-2-microglobulin antibodies. The extent of amyloid deposits in the muscularis propria, myenteric plexuses, and blood vessels was graded from -to + + + : -, absent; + , mild; + + , moderate; + + + , severe. The smooth muscle replacement and degeneration or reduction of the myenteric plexuses were also graded from -to ++ + .
Results
CHEMICAL TYPES OF AMYLOID PROTEIN
According to the results of immunohistochemistry and sensitivity to KMn04 reaction, there were 13 patients with AA amyloidosis, two with AL, and one with AH. Good correlation was noted between clinical classification and the expected amyloid type in 15 of 16 patients; the 12 patients with secondary amyloidosis had AA, two with multiple myeloma had AL, one with longterm haemodialysis had AH. An exceptional case, who was clinically classified as primary amyloidosis because no predisposing disease could be recognised, showed deposits of AA protein as evidenced by a positive stain for anti-AA antibody, which was sensitive to KMn04 reaction.
CLINICAL FEATURES All 16 patients suffered from similar symptoms such as nausea, vomiting, abdominal distension, and pain. The patients had either diarrhoea or constipation. Malnutrition was evident in all patients whose laboratory data showed hypoalbuminaemia (mean (SD) was 2·6 (0·6) mg/dl, ranging from 1·0 to 3·5 mg/dl). The duration of obstructive symptoms varied widely with a range from a few weeks to several years. Thirteen had an acute or subacute self limiting condition, but the remaining three had several years history 'of recurrent obstructive symptoms. Table I summarises the clinical features and chemical types of amyloid protein.
We found differences in the clinical signs between amyloid types. The patients with AL and AH presented with chronic, intermittent, obstructive symptoms, which developed into a severe form that required admission to hospital. The patients with AA had no chronic obstructive symptoms until they developed an acute condition with apparent intestinal obstruction. In all patients, plain films of the abdomen showed abnormal gastrointestinal gas. Considerable gaseous dilatation of the small and large bowel was consistently seen in the AL and the AH patients during their hospital stay (Fig 1) , whereas the abnormal gas disappeared after treatment-in 12 of 13 patients with AA (Fig 2) .
All patients received total parenteral nutrition treatment. The daily maintenance dose of calories was 2000 to 2400 kcal (40-60 kcal/kg body weight). The average period of treatment was 10·3 (6·7) weeks, ran ging from 2 to 28 weeks. One patient with AA died shortly after the start of total par enteral nutrition because of renal failure and sepsis. In 12 patients, all of whom were AA, total parenteral nutrition was effective in improving symptoms and signs, and thereafter, made it possible to maintain adequate oral intake again. In these AA patients, there was -, 
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Disc ussion
The main finding of th is study is that if intestinal pseudo-obs truction develops in patients .....ith am yloidosis, the clinical featu res are considerably different according to the chemical types of amyloid protein. Acute or subacute self Iimili ng and blood vessels of the small int estine. In comparing the AA, AL , and AH cases, we found an appreciable difference in the degree of amyloid deposits in the muscularis propria . By contrast with negative or slight smooth muscle infiltration in the AA cases, the muscularis was qu ite extensively affected in the AL (Fig 3) and the AH cases (Fig 4) . In cases with massive deposits, there were degenerative changes in muscle fibres, with mu scle tissue being replaced by amyloid.
Amyloid was found in the myenteric plexuses in the AA cases (Fig 5) . The degree of amyloid deposition in the myenteric plexuses varied widely; some were free of amyloid in certain areas, while massive amyloid deposits were evident in others . In plexuses with amyloid deposits, some residu al ganglion cells showed degenerative changes. In the AL and AH cases, we could not find any amyloid in the myenteric plexuses. Man y Auerbach's plexuses were compressed, however , by the surro unding abundant amyloid deposits, with a d iminu tion in their num ber and the presence of degenerative ganglion cells.
In all Cases, vascular deposits of amyloid were found most commonly in the subm ucosa. Massive vascular deposits were found in the AA cases, while the degree was moderate in the AL and slight in the AH .
These histological findings were similar in all part s of the gastrointestinal tract. The degree of amyloid deposition, however , was greatest in the small intestine . no recurrence of paralyti c ileus or severe obstructive symptoms during the follow up ranging from 1·9 to 10'6 years (average 5, ( years), although minor symptoms occasionally occurred . In the remaini ng three patients (AL in two and AH in one). however , the obstructive symptoms were persiste nt and qu ite resistant to total parenteral nutrition treatment . Medical treatments such as cholinergic agents, meroctopramid e, and cisapride were also ineffective. All of them eventuall y died of cardiac failur e without the return 10normal bowel function .
NECROPSY fi NDINGS
In all seven necropsy cases, amyloid was found in every site of the gastrointestinal tract including the oesop hagus, stomach, small, and large int estines. Table 11 shows the degree of amyloid deposition and destruction of organic structures in th e mu scularis propria, myenteric plexuses ,
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• . ' . . Recently, a new form of amyloid protein associated with longterm haemodialysis has been identified as P2-microglobulin. '3 Gastrointestinal iRvolvement by amyioid has been reported in dialysis patients, and there have been cases of intestinal infarction associated with massive amyloid deposits in the muscle layers of the bowel.'`2` Akhough only a few cases have been studied, it seems probable that extensive infiltration and smooth muscle replacement by amyioid deposits occur in patients with AH amyloidosis, as shownin our case. Tada, Iida, Yao, Kitamoto, Yao, Fwfishima Myenteric piexuses often participate in famjlial amyloid poiyneuropathy20 and in a few cases with AL22 and AA.` In this study, pathological examination of the necropsy specimens showed that amyloid deposits in the myenteric plexuses were seen enly in the AA cases.
Interestingly, 12 of our 13 patients with AA showed a remarkable improvement in bowel function after receiving total parenteral nutrition treatment. ASthough total parenteral nutrition does nothing to treat the primary disease directly, it helps the patient receive enough nutrition until bowel functions return to normal again. 25 Our ciinicai findings suggest that the neuronai disorder may be compensated to some degree because the intestines are richly innervated.i If the muscularis propria escapes extensive damage, we assume that the impaired bowei propugsion is ailowed to recover to some extent. On the other hand, vascular insufficiency might also have contributed to the impaired peristalsis,6 because appreciable.vascular deposits were seen in our AA cases. Further examinations are required, however, to know the exact correiation between them.
In this study, differences in the histologicai sites of amyioid depo$its between the chemical types of amyioid affected the clinicai signs of intestinal pseudo-obstruction. Our findings suggest that this disease usually runs a more serious course in AL and AH than in AA. Recent reports show that ciinical and histolggicaX differences in the preferential sites of amyioid deposition between the chemical types of amyloid exist in the heart,i5 kidney,26 and spleen.2' In the heart, clinicaliy signtficant cardiac amySoid with congestive heart failure is more likeRy in AL than in AA, because extensive amyloid interstitial infiltration in the myocardium is more often seen in AL than in AA.'O '2 '5 In patients with amyloidosis, therefore, we beiieve that chemical typing of the amyloid protein is very important in predicting the clinical characteristics, course, and prognosis of the disease.
